Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- CheckyesterdayChange DetectedThe site revision has been updated to v3.6.5, replacing the previous v3.6.4, indicating a routine update with no visible changes to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision on the page updated from v3.6.3 to v3.6.4, indicating a minor platform update. This change does not modify study details, eligibility criteria, or results.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe revision tag on the page was updated to v3.6.3, signaling a new revision of the study record.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.6.2 is now displayed in place of v3.6.0, indicating a software/UI update for the study page. The change does not affect study data or eligibility information.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now indicates that recruitment is closed and adds new guidance sections for understanding and joining the study, while the Intervention/Treatment header formatting changes and an older revision tag are removed.SummaryDifference0.5%

- Check65 days agoChange DetectedThe page now shows a new revision label, v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record's metadata/versioning rather than a substantive change to study details.SummaryDifference0.1%

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.